Ferring Pharmaceuticals Inc recalls Bravelle 75 IU (urofollitropin for injection, purified) For Subcutaneous or Intramuscular Injection Only, 1 Carton (con…

Recall date

September 9, 2015

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0015-2016

FDA classification

Class III

Brand / firm

Ferring Pharmaceuticals Inc

Sold / distributed

Nationwide

Why it was recalled

Subpotent Drug

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Bravelle 75 IU (urofollitropin for injection, purified) For Subcutaneous or Intramuscular Injection Only, 1 Carton (contains 5 single dose vials of Bravelle, 5 single dose vials of 0.9% Sodium Chloride Inj., USP, 2 mL, and 5 Q-Cap Vial Adaptors) , Rx Only, Manufactured for: Ferring Pharmaceuticals, Inc. Parsippany, NJ 07054, By: Ferring Gmbh, Kiel Germany, NDC 55566-8505-6